S&P 500   4,482.73
DOW   34,715.39
QQQ   361.72
S&P 500   4,482.73
DOW   34,715.39
QQQ   361.72
S&P 500   4,482.73
DOW   34,715.39
QQQ   361.72
S&P 500   4,482.73
DOW   34,715.39
QQQ   361.72

Pro-Dex Stock Forecast, Price & News

-0.55 (-2.23%)
(As of 01/20/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
8,838 shs
Average Volume
6,003 shs
Market Capitalization
$88.21 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Pro-Dex logo

About Pro-Dex

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical device and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.


See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$38.03 million
Cash Flow
$1.36 per share
Book Value
$5.50 per share


Net Income
$4.45 million
Pretax Margin




Free Float
Market Cap
$88.21 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.49 out of 5 stars

Medical Sector

1095th out of 1,418 stocks

Surgical & Medical Instruments Industry

106th out of 130 stocks

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -

Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

How has Pro-Dex's stock price been impacted by Coronavirus (COVID-19)?

Pro-Dex's stock was trading at $18.24 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PDEX stock has increased by 32.1% and is now trading at $24.10.
View which stocks have been most impacted by COVID-19

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Pro-Dex

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) released its earnings results on Monday, November, 15th. The medical instruments supplier reported $0.28 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.28. The medical instruments supplier earned $9.99 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 20.30% and a net margin of 10.77%.
View Pro-Dex's earnings history

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the following people:

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex CEO Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among Pro-Dex's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $24.10.

How much money does Pro-Dex make?

Pro-Dex has a market capitalization of $88.21 million and generates $38.03 million in revenue each year. The medical instruments supplier earns $4.45 million in net income (profit) each year or $1.08 on an earnings per share basis.

How many employees does Pro-Dex have?

Pro-Dex employs 119 workers across the globe.

What is Pro-Dex's official website?

The official website for Pro-Dex is www.pro-dex.com.

Where are Pro-Dex's headquarters?

Pro-Dex is headquartered at 2361 MCGAW AVENUE, IRVINE CA, 92614.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at [email protected], or via fax at 949-769-3281.

This page was last updated on 1/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.